98%
921
2 minutes
20
MicroRNA (miRNA) is a promising biomarker for the early diagnosis of pancreatic cancer. To enable sensitive and reliable miRNA detection, we have developed a one-pot isothermal CRISPR/Dx detection system by combining rolling circle amplification (RCA) and CRISPR/Cas12a. RCA and CRISPR/Cas12a reactions are carried out in a single closed tube, bypassing the transferring step. We demonstrate the feasibility of our one-pot CRISPR/Dx system in detecting pancreatic cancer by targeting miR-25, miR-191, miR-205, and miR-1246. When applied to fluorescence- and lateral flow strip paper-based detection platforms, our one-pot CRISPR/Dx system detects synthetic miR-25 at a LOD of 6.60 fM and 500 fM, respectively. It has high targeting specificity, as shown by its ability to discriminate miR-25 with a single-base mutation and highly homologous miRNA species. It is also successfully generalized to detect other pancreatic cancer-associated miRNAs, including miR-191, miR-205, and miR-1246. Importantly, our one-pot CRISPR/Dx system enables specific and sensitive detection of endogenous miR-25 in the human pancreatic cancer cell line PANC-1. We have successfully developed a one-pot isothermal CRISPR/Dx system for detecting miRNA with high specificity and sensitivity. It is highly flexible and economical, as a common crRNA can detect different miRNAs and only requires minor modifications to the locking padlock probe. Therefore, it can potentially be translated into clinical settings and POCT for the diagnosis of various human cancers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d4ay01695e | DOI Listing |
Anal Methods
August 2025
Department of Biology, College of Science, Shantou University, Shantou, Guangdong, China.
Targeted therapies directed at fusion genes have proven remarkably effective against cancers. Therefore, the rapid and reliable identification of cancer fusion genes can guide subsequent therapeutic treatment and predict prognosis. By integrating the RT-RPA and CRISPR/Cas12a approaches, we developed a one-pot CRISPR/Dx system for the rapid and multiplex detection of cancer fusion genes.
View Article and Find Full Text PDFBiosens Bioelectron
November 2025
Department of Pathology, Fujian Cancer Hospital, Fuzhou, Fujian, China. Electronic address:
To realize point-of-care testing (POCT) for human diseases, CRISPR/Cas technology has been integrated with commercial analytical devices and chromogenic substrates such as personal glucose meter (PGM), pregnancy test strips (PTS), and horseradish peroxidase (HRP). These integrated detection platforms enable portable diagnostics, economical, universal, rapid, and high throughput detection. The change in color and electrochemical signal enables visible signal readout and intuitive results without specialized equipment and skillful operators.
View Article and Find Full Text PDFBiosens Bioelectron
October 2025
School of Medicine, South China University of Technology, Guangzhou, China; Dermatology Hospital, Southern Medical University, Guangzhou, China. Electronic address:
The development of clustered regularly interspaced short palindromic repeats (CRISPR)-based nucleic acid detection has recently been a center of interest for next-generation molecular diagnostics. Despite considerable advances, simple and effective strategies to harness the isothermal amplification reaction and CRISPR-based detection for maximal performance and minimal complexity are still desirable. Here, a thermofluidic approach leverages the micro-scale chemical and physical mechanism to perform autonomous and scalable CRISPR-based diagnostics (CRISPR-Dx) in a greatly simplified format, which was called "Thermofluidic CRISPR".
View Article and Find Full Text PDFProc Natl Acad Sci U S A
March 2025
Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Rapid and accurate detection of DNA from disease-causing pathogens is essential for controlling the spread of infections and administering timely treatments. While traditional molecular diagnostics techniques like PCR are highly sensitive, they include nucleic acid amplification and many need to be performed in centralized laboratories, limiting their utility in point-of-care settings. Recent advances in CRISPR-based diagnostics (CRISPR-Dx) have demonstrated the potential for highly specific molecular detection, but the sensitivity is often constrained by the slow trans-cleavage activity of Cas enzymes, necessitating preamplification of target nucleic acids.
View Article and Find Full Text PDFAnal Methods
February 2025
School of Electrical and Computer Engineering, University of Tehran, Tehran, Iran.
In recent years, CRISPR (clustered regularly interspaced short palindromic repeats) has emerged as a detection technique with high specificity and sensitivity. However, it still needs improvements in terms of reducing cost, complexity, cross-contamination, technical requirements, and lack of quantification platforms. Microfluidic strategies can advance CRISPR-based technology and be modified to a higher level in the future.
View Article and Find Full Text PDF